Full text

Turn on search term navigation

© 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objectives

Individuals who receive a negative lateral flow coronavirus test result may misunderstand it as meaning ‘no risk of infectiousness’, giving false reassurance. This experiment tested the impact of adding information to negative test result messages about residual risk and the need to continue protective behaviours.

Design.

4 (residual risk) × 2 (post-test result behaviours) between-subjects design.

Setting.

Online.

Participants

1200 adults from a representative UK sample recruited via Prolific (12–15 March 2021).

Interventions

Participants were randomly allocated to one of eight messages. Residual risk messages were: (1) ‘Your coronavirus test result is negative’ (control); (2) message 1 plus ‘It’s likely you were not infectious when the test was done’ (current NHS Test & Trace (T&T); (3) message 2 plus ‘But there is still a chance you may be infectious’ (elaborated NHS T&T); and (4) message 3 plus infographic depicting residual risk (elaborated NHS T&T+infographic). Each message contained either no additional information or information about the need to continue following guidelines and protective behaviours.

Outcome measures

(1) Proportion understanding residual risk of infectiousness and (2) likelihood of engaging in protective behaviours (scales 1–7).

Results

The control message decreased understanding relative to the current NHS T&T message: 54% versus 71% (Adjusted Odds Ratio (AOR)=0.56 95% CI 0.34 to 0.95, p=0.030). Understanding increased with the elaborated NHS T&T (89%; AOR=3.25 95% CI 1.64 to 6.42, p=0.001) and elaborated NHS T&T+infographic (91%; AOR=5.16 95% CI 2.47 to 10.82, p<0.001) compared with current NHS T&T message. Likelihood of engaging in protective behaviours was unaffected by information (AOR=1.11 95% CI 0.69 to 1.80, χ2(1)=0.18, p=0.669), being high (M=6.4, SD=0.9) across the sample.

Conclusions

A considerable proportion of participants misunderstood the residual risk following a negative test result. The addition of a single sentence (‘But there is still a chance you may be infectious’) to current NHS T&T wording increased understanding of residual risk.

Trial registration number

OSF: https://osf.io/byfz3/

Details

Title
Impact of residual risk messaging to reduce false reassurance following test-negative results from asymptomatic coronavirus (SARS-CoV-2) testing: an online experimental study of a hypothetical test
Author
Batteux, Eleonore 1   VIAFID ORCID Logo  ; Bonfield, Stefanie 1   VIAFID ORCID Logo  ; Jones, Leah Ffion 1   VIAFID ORCID Logo  ; Carter, Holly 1   VIAFID ORCID Logo  ; Gold, Natalie 2   VIAFID ORCID Logo  ; Amlot, Richard 3   VIAFID ORCID Logo  ; Marteau, Theresa 4   VIAFID ORCID Logo  ; Weston, Dale 1   VIAFID ORCID Logo 

 Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK 
 Department of Behavioural Insights, Public Health England, London, UK; Centre for the Philosophy of Natural and Social Science, The London School of Economics and Political Science, London, UK 
 Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK; Department of Psychological Medicine, King's College London, London, UK 
 Behaviour and Health Research Unit, University of Cambridge, Cambridge, UK 
First page
e056533
Section
Public health
Publication year
2022
Publication date
2022
Publisher
BMJ Publishing Group LTD
e-ISSN
20446055
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2640058987
Copyright
© 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.